Story
Genscript Biotech Stock Surges Over 16% on Eli Lilly AI Partnership
Shares of Genscript Biotech (1548.HK) surged on Thursday, closing up 16.2% at HK$37.82 after the company announced a strategic partnership with an initiative from pharmaceutical giant Eli Lilly.
AI Drug Discovery Collaboration
The catalyst for the rally was Genscript's collaboration with Lilly TuneLab™, an AI and machine learning-powered drug discovery platform. Under the agreement, Genscript will provide crucial wet lab services to support the initiative.
This role involves translating computational predictions generated by Lilly's AI into tangible biological validation data. The objective is to significantly accelerate the evaluation process for new drug candidates, bridging the gap between digital modeling and real-world laboratory results.
AdStrategic Funding and Sector Rally
The partnership news follows Genscript's recent completion of a substantial share placement that raised approximately HK$2.35 billion in net proceeds. The company has designated about 70% of this capital to scale up its own AI drug discovery platform and infrastructure, with another 20% allocated for related research and development.
Investor enthusiasm extended beyond Genscript, lifting other companies in Hong Kong's Contract Research Organization (CRO) sector. The move suggests a broader re-rating by the market of companies with exposure to the growing field of AI-assisted drug discovery. This targeted rally occurred even as the broader Hang Seng index fell by 0.9%.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.